Cargando…

Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion

Osteoporosis is a degenerative metabolic disease caused by an imbalance between osteogenesis and osteoclastogenesis. Increased levels of proinflammatory cytokines combined with decreased estrogen levels, which are commonly seen in postmenopausal women, can lead to overactivation of osteoclasts. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyun Young, Kim, Kyeong Seok, Kim, Myung Ji, Kim, Hyung-Shik, Lee, Kwang-Youl, Kang, Keon Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561666/ https://www.ncbi.nlm.nih.gov/pubmed/31275508 http://dx.doi.org/10.1155/2019/3503912

Ejemplares similares

Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome
por: Kim, Hyun Young, et al.
Publicado: (2021)

TRPM7 Is Essential for RANKL-Induced Osteoclastogenesis
por: Yang, Yu-Mi, et al.
Publicado: (2013)

Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts
por: Lee, Do-Won, et al.
Publicado: (2018)

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity
por: Hur, Jeonghwan, et al.
Publicado: (2016)

Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin
por: Kim, Hyun Young, et al.
Publicado: (2023)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis
por: Kim, Jeong Yeon, et al.
Publicado: (2012)

Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1
por: Song, Min-Kyoung, et al.
Publicado: (2015)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
por: Choi, Joo-Hee, et al.
Publicado: (2018)

Attenuated RANKL-induced cytotoxicity by Portulaca oleracea ethanol extract enhances RANKL-mediated osteoclastogenesis
por: Erkhembaatar, Munkhsoyol, et al.
Publicado: (2015)

STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis
por: Lee, Jongwon, et al.
Publicado: (2016)

Inhibitory effects of ChondroT and its constituent herbs on RANKL-induced osteoclastogenesis
por: Guo, Rui Hong, et al.
Publicado: (2019)

Mitf Induction by RANKL Is Critical for Osteoclastogenesis
por: Lu, Ssu-Yi, et al.
Publicado: (2010)

Protaetia brevitarsis Extract Attenuates RANKL-Induced Osteoclastogenesis by Inhibiting the JNK/NF-κB/PLCγ2 Signaling Pathway
por: Jang, Hye-Yeon, et al.
Publicado: (2023)

Activation of G Proteins by Aluminum Fluoride Enhances RANKL-Mediated Osteoclastogenesis
por: Park, Boryung, et al.
Publicado: (2013)

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB
por: Quan, Gui-Hua, et al.
Publicado: (2015)

RANKL-induced DC-STAMP Is Essential for Osteoclastogenesis
por: Kukita, Toshio, et al.
Publicado: (2004)

RANKL Signaling and Osteoclastogenesis Is Negatively Regulated by Cardamonin
por: Sung, Bokyung, et al.
Publicado: (2013)

Isoliquiritigenin Derivatives Inhibit RANKL-Induced Osteoclastogenesis by Regulating p38 and NF-κB Activation in RAW 264.7 Cells
por: Jeong, Seongtae, et al.
Publicado: (2020)

TNF-α and RANKL promote osteoclastogenesis by upregulating RANK via the NF-κB pathway
por: Luo, Gang, et al.
Publicado: (2018)

Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis
por: Lombardi, Maria Stella, et al.
Publicado: (2017)

Pasteurella multocida Toxin Triggers RANKL-Independent Osteoclastogenesis
por: Chakraborty, Sushmita, et al.
Publicado: (2017)

CCL4 enhances preosteoclast migration and its receptor CCR5 downregulation by RANKL promotes osteoclastogenesis
por: Lee, Dabin, et al.
Publicado: (2018)

Effects of Inositol 1,4,5-triphosphate on Osteoclast Differentiation in RANKL-induced Osteoclastogenesis
por: Son, Aran, et al.
Publicado: (2012)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
por: Kang, Moo Rim, et al.
Publicado: (2014)

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities
por: Joung, Youn Hee, et al.
Publicado: (2016)

Galangin suppresses RANKL‐induced osteoclastogenesis via inhibiting MAPK and NF‐κB signalling pathways
por: Li, Xiucheng, et al.
Publicado: (2021)

Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL-induced NF-κB signaling pathway
por: Cai, Pan, et al.
Publicado: (2022)

Eudebeiolide B Inhibits Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Induced NF-κB, c-Fos and Calcium Signaling
por: Kim, Mi-Hwa, et al.
Publicado: (2020)

N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2019)

NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides
por: Alam, Mohammad Ibtehaz, et al.
Publicado: (2022)

Water Extracts of Hull-less Waxy Barley (Hordeum vulgare L.) Cultivar ‘Boseokchal’ Inhibit RANKL-induced Osteoclastogenesis
por: Kim, Kwang-Jin, et al.
Publicado: (2019)

Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis
por: Kim, Hae-Rim, et al.
Publicado: (2011)

Barley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of Osteoclastogenesis
por: Choi, Sik-Won, et al.
Publicado: (2017)

The molecular mechanism of osteoclastogenesis: ODF/RANKL-dependent and independent pathways
por: Suda, T, et al.
Publicado: (2001)

Follicle-Stimulating Hormone Does Not Impact RANKL-Induced Osteoclastogenesis
por: Zhou, Ziyue, et al.
Publicado: (2021)

Tetrandrine inhibits RANKL-induced osteoclastogenesis by promoting the degradation of TRAIL
por: Li, Jiarui, et al.
Publicado: (2022)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

Nepetin inhibits osteoclastogenesis by inhibiting RANKL‐induced activation of NF‐κB and MAPK signalling pathway, and autophagy
por: Chu, Binxiang, et al.
Publicado: (2020)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
por: Zhu, Mengbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hla3lm47mjiq6o2btn5eult65u